We confirmed the inverse correlation between CPEB1 expression and methylation of its promoter in the SW480 and HCT116 CRC cancer cell lines that were treated with the methylation inhibitor, 5-Aza-dC (5-aza-2′-deoxycytidine, DAC). This evidence concerns the gene CPEB1 and colorectal carcinoma.